D. Bakkaloglu Et Al. , "The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry," VIRCHOWS ARCHIV , vol.469, 2016
Bakkaloglu, D. Et Al. 2016. The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry. VIRCHOWS ARCHIV , vol.469 .
Bakkaloglu, D., CIFTCI, H. S., MUSLUMANOGLU, O. A. H., EKIZOGLU, S., CINAR, Ç., AR, M. C., ... TUZUNER, N.(2016). The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry. VIRCHOWS ARCHIV , vol.469.
Bakkaloglu, Doğu Et Al. "The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry," VIRCHOWS ARCHIV , vol.469, 2016
Bakkaloglu, Doğu V. Et Al. "The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry." VIRCHOWS ARCHIV , vol.469, 2016
Bakkaloglu, D. Et Al. (2016) . "The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry." VIRCHOWS ARCHIV , vol.469.
@article{article, author={Doğu VURALLI BAKKALOĞLU Et Al. }, title={The incidence & prognostic impact of ASXL1 mutations/protein expression in myeloid stem cell diseases with concurrent bone marrow fibrosis and concordance between Sanger sequencing & immunohistochemistry}, journal={VIRCHOWS ARCHIV}, year=2016}